SK DiscoverySK디스커버리
006120 · KOSPI · ₩006120 · SK디스커버리
- Market cap
- ₩1T
- Enterprise value
- ₩1.9T
- P/E
- 5.5×
- P/B
- 0.3×
- Dividend yield
- 3.4%
- ROE
- 5.2%
- Net margin
- 1.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−19.3% from the high
₩42,750Today: ₩57,600 – ₩59,900₩73,000
Returns
- 1W−14.5%
- 1M−2.3%
- 3M+18.4%
- 6M+3.0%
- YTD+1.9%
- 1Y+1.9%
- Volume today
- 23,442
- 0.6× the 20-day average
- Traded today
- ₩1.4B
- Listed shares
- 17,413,751
- EPS (12 months)
- ₩10,774
- Earnings yield 18.3%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 34 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Only a routine shareholding filing, with no clear positive or negative news. Community: 0 bullish, 0 bearish posts this week.
- MomentumFlat2.4% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
SK Discovery stock overview
SK Discovery (SK디스커버리, KRX: 006120) is listed on KOSPI, in the Holding companies sector. SK Discovery is a pure holding company that does not run its own business and instead owns operating subsidiaries across eco-friendly materials and pharmaceuticals, LPG gas, plasma-derived therapies, real estate development, renewable energy, real estate data, and vaccines and biopharmaceuticals. Its shares closed at ₩58,900 on Oct 27, 2026, up 3.15% on the day, giving it a market value of ₩1T.
Key facts
- Market cap
- ₩1T
- Sector
- Holding companies
- Latest price change
- +3.15%
- As of
- Oct 27, 2026
- Main business
- SK Discovery is a pure holding company that does not run its own business and instead owns operating subsidiaries across eco-friendly materials and pharmaceuticals, LPG gas, plasma-derived therapies, real estate development, renewable energy, real estate data, and vaccines and biopharmaceuticals.
Quick answers about SK Discovery
- What does SK Discovery do?
- SK Discovery is a pure holding company that does not run its own business and instead owns operating subsidiaries across eco-friendly materials and pharmaceuticals, LPG gas, plasma-derived therapies, real estate development, renewable energy, real estate data, and vaccines and biopharmaceuticals. Its main subsidiaries include SK Chemicals, which produces Copolyester resins and pharmaceuticals such as Ginexin-F, SK Gas, which imports, stores and sells LPG for transport, petrochemical, heating and cooking uses, and SK Plasma, which makes plasma-derived products such as SK Albumin. Other subsidiaries and affiliates operate in office and commercial property development, wind, solar and fuel-cell power, property data services, vaccine manufacturing for products such as flu and shingles vaccines, and power and steam supply, with operations centered on plants in Korea such as Ulsan, Pyeongtaek and Andong.
- What is the market cap of SK Discovery?
- The market capitalisation of SK Discovery was ₩1T at the close on Oct 27, 2026.
- Who are the largest shareholders of SK Discovery?
- According to the latest official filings, the largest reported holders are Choi Chang-won (56.46%, as of Aug 19, 2026); National Pension Service (5.04%, as of Apr 1, 2026); DALTONINVESTMENTS,INC. (5.00%, as of Oct 28, 2026).
- When is the next earnings report from SK Discovery?
- Korean companies rarely announce results dates in advance. Based on when SK Discovery filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own SK Discovery?
- Yes. The National Pension Service held 5.04% of SK Discovery shares as of Apr 1, 2026.
Company profile
SK Discovery is a pure holding company that does not run its own business and instead owns operating subsidiaries across eco-friendly materials and pharmaceuticals, LPG gas, plasma-derived therapies, real estate development, renewable energy, real estate data, and vaccines and biopharmaceuticals. Its main subsidiaries include SK Chemicals, which produces Copolyester resins and pharmaceuticals such as Ginexin-F, SK Gas, which imports, stores and sells LPG for transport, petrochemical, heating and cooking uses, and SK Plasma, which makes plasma-derived products such as SK Albumin. Other subsidiaries and affiliates operate in office and commercial property development, wind, solar and fuel-cell power, property data services, vaccine manufacturing for products such as flu and shingles vaccines, and power and steam supply, with operations centered on plants in Korea such as Ulsan, Pyeongtaek and Andong.
Written by AI from the company's latest annual report.
- Korean name
- SK디스커버리
- Sector
- Holding companies
- Business group
- SK
- CEO
- 최창원, 손현호
- Founded
- Jul 1969
- Listed
- Jun 1976
- Listed shares
- 17,413,751
- Fiscal year ends
- Month 12
- Website
- www.skdiscovery.com
Similar companies
- SK Square402340 · ₩109T₩828,000+7.67%
- KB Financial Group105560 · ₩52T₩147,600+0.27%
- Shinhan Financial Group055550 · ₩40T₩85,800+0.35%
- SK034730 · ₩36T₩497,500+6.87%
- Hana Financial Group086790 · ₩31T₩113,300+0.80%
- Woori Financial Group316140 · ₩21T₩28,850−1.37%
- Meritz Financial Group138040 · ₩21T₩123,000−1.76%
- HD Korea Shipbuilding & Offshore Engineering009540 · ₩17T₩246,500+1.44%
Recent filings
See all- 5%+ holding reportOct 28, 2026
- Buyback trust contract signedOct 13, 2026
- [Amendment] New Facility Investment, etc. (Major Management Matters of Subsidiary)Sep 18, 2026
- Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)Sep 11, 2026
- Amended: Major sales or supply contractSep 11, 2026
Titles in Korean until English translations are added.
Also known as: SK Discovery / SK디스커버리 / 006120 / KRX:006120
Source: KRX statistical information